| 國家衛生研究院 |
2010-11 |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
Lin, KM;Tsou, HH;Tsai IJ;Hsiao, MC;Hsiao, CF;Liu CY;Shen, WW;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Kuo, HW;Liu, SC;Chan, HW;Hsu, YT;Tian, JN;Liu, YL |
| 國立臺灣大學 |
2010 |
Cyp1a2 Genetic Polymorphisms Are Associated with Treatment Response to the Antidepressant Paroxetine
|
林克明; 鄒小蕙; 蕭美君; 蕭金福; 劉嘉逸; 沈武典; 湯華盛; 方俊凱; 吳其炘; 呂紹俊; 郭湘維; LIN, KEH-MING; TSOU, HSIAO-HUI; HSIAO, MEI-CHUN; HSIAO, CHIN-FU; LIU, CHIA-YIH; SHEN, WINSTON W.; TANG, HWA-SHENG; FANG, CHUN-KAI; WU, CHI-SHIN; LU, SHAO-CHUN; KUO, HSIANG-WEI; LIU, YU-LI |
| 中國醫藥大學 |
2010 |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
林克明(Keh-Ming Lin)*; 劉玉麗(Liu, Yu-Li)* |
| 臺大學術典藏 |
2020-02-06T08:11:29Z |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; Wu C.-S.; SHAO-CHUN LU; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L.; Lin K.-M.;Tsou H.-H.;Tsai I.-J.;Hsiao M.-C.;Hsiao C.-F.;Liu C.-Y.;Shen W.W.;Tang H.-S.;Fang C.-K.;Wu C.-S.;Shao-Chun Lu;Kuo H.-W.;Liu S.C.;Chan H.-W.;Hsu Y.-T.;Tian J.-N.;Liu Y.-L.; Lin K.-M.; Tsou H.-H.; Tsai I.-J. |
| 國家衛生研究院 |
2012-03 |
CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage
|
Liu, Y;Tian, J;Kuo, H;Tsou, H;Liu, S;Lu, S;Lin, K;Chen, Y |
| 國立中山大學 |
2013-07-23 |
CYP26B1 及相關蛋白質在檳榔引發口腔癌之研究
|
許正傑 |
| 高雄醫學大學 |
2012 |
CYP27A1 polymorphism 與有代謝症候群男性之脂肪激素和膽固醇代謝顯著相關
|
鄭凱鴻;劉家駒;黃俊農;李永進;朱志生;眭致遠;賴文德;黃書彬 |
| 高雄醫學大學 |
2012 |
CYP27A1 polymorphism 與有代謝症候群男性之脂肪激素和膽固醇代謝顯著相關
|
鄭凱鴻;劉家駒;黃俊農;李永進;朱志生;眭致遠;賴文德;黃書彬 |
| 臺北醫學大學 |
2004 |
CYP2B1/2 contributes to propofol metabolism to 4-hydroxy-propofol in rat liver.
|
陳瑞明; Lin YL; Chen TL; Chen RM; |
| 國家衛生研究院 |
2011-08 |
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer
|
Wang, SC;Ho, IK;Tsou, HH;Tian, JN;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Chen, CY;Liu, SC;Wu, HY;Chan, HW;Tsai, MH;Lin, PS;Liu, YL |
| 中國醫藥大學 |
2011-08 |
CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer
|
(Wang SC);(Ho IK);(Tsou HH);(Tian JN);(Hsiao CF);(Chen CH);(Tan HK);(Lin L);(Wu CS);(Su LW);黃介良(Chieh-Liang Huang);(Yang YH);(Liu ML);(Lin KM);(Chen CY);(Liu SC);(Wu HY);(Chan HW);(sai MH);(Lin PS);(Liu YL)* |
| 臺大學術典藏 |
2020-11-04T09:17:20Z |
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer
|
Wang S.-C.; Ho I.-K.; Tsou H.-H.; Tian J.-N.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Chen C.-Y.; Liu S.C.; Wu H.-Y.; Chan H.-W.; Tsai M.-H.; Lin P.-S.; Liu Y.-L. |
| 國立成功大學 |
2008-08 |
CYP2C19 genotypes and Helicobacter pylori eradication
|
Sheu, Bor-Shyang; Fock, Kwong-Ming |
| 國立成功大學 |
2012-01 |
CYP2C19 genotypes determine the efficacy of on-demand therapy of pantoprazole for reflux esophagitis as Los-Angeles grades C and D
|
Sheu, Bor-Shyang; Cheng, Hsiu-Chi; Yeh, Yi-Chun; Chang, Wei-Lun |
| 國立臺灣大學 |
2010 |
Cyp2c19 Genotypes in the Pharmacokinetics/Pharmacodynamics of Proton Pump Inhibitor-Based Therapy of Helicobacter Pylori Infection
|
楊智欽; 林君榮; YANG, JYH-CHIN; LIN, CHUN-JUNG |
| 臺大學術典藏 |
2018-09-10T08:02:38Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
Yang, J.-C.;Lin, C.-J.; CHUN-JUNG LIN; JYH-CHIN YANG |
| 臺大學術典藏 |
2021-06-04T03:09:19Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
Yang J.-C.; CHUN-JUNG LIN |
| 臺大學術典藏 |
2022-03-04T08:22:49Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J. |
| 臺大學術典藏 |
2021-05-27T02:50:13Z |
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J. |
| 義守大學 |
2014-11 |
CYP2C19 polymorphism influences Helicobacter pylori eradication
|
Chao-Hung Kuo;Chien-Yu Lu;Hsiang-Yao Shih;Chung-Jung Liu;Meng-Chieh Wu;Huang-Ming Hu;Wen-Hung Hsu;Fang-Jung Yu;Deng-Chyang Wu;Fu-Chen Kuo |
| 臺大學術典藏 |
2020-03-09T04:23:59Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.;Nai-Chen Cheng;Tai H.;Jimmy Juang J.;Wu C.;Lin L.;Hwang J.;Lin J.;Chiang F.;Tsai C.; Lee J.; NAI-CHEN CHENG; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2020-12-04T07:44:32Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; LIAN-YU LIN; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2020-12-30T08:47:32Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Jimmy Juang J.; Cheng N.; Tai H.; Lee J.; Wu C.; Lin L.; Hwang J.; Lin J.; Chiang F.; CHIA-TI TSAI |
| 臺大學術典藏 |
2019 |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Wu C.; Tai H.; Jimmy Juang J.; Cheng N.; Lee J.; Lin L.; HWANG, JUEY-JEN; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2022-03-07T07:05:30Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
JEN-KUANG LEE; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2021-03-11T04:29:15Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.;Cheng N.;Tai H.;Jimmy Juang J.;Wu C.;Lin L.;Hwang J.;Lin J.;Fu-Tien Chiang;Tsai C.; Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; Hwang J.; Lin J.; FU-TIEN CHIANG; Tsai C. |
| 臺大學術典藏 |
2020-12-02T11:04:26Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Tsai C.; Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; CHO-KAI WU; Lin L.; Hwang J.; Lin J.; Chiang F. |
| 臺大學術典藏 |
2022-09-06T02:41:27Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; LIAN-YU LIN; Hwang J.; Lin J.; Chiang F.; Tsai C. |
| 臺大學術典藏 |
2022-09-20T06:48:37Z |
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia
|
Lee J.; Cheng N.; Tai H.; Jimmy Juang J.; Wu C.; Lin L.; HWANG, JUEY-JEN; Lin J.; Chiang F.; Tsai C. |
| 國立臺灣大學 |
2008 |
CYP2C19基因多型性對短療程rabeprazole三合一療法之藥動/藥效關係及療效影響之評估
|
楊喻帆; Yang, Yu-Fan |
| 高雄醫學大學 |
2010 |
CYP2C19基因多型性對第一線幽門桿菌除菌治療的影響-比較四種PPI的處方
|
郭昭宏;王聖雯;翁碧娟;賴俊煌;黃耀康;吳登強 |
| 高雄醫學大學 |
2008 |
CYP2C19基因多型性與抗生素抗藥性在levofloxacin為主的救援療法扮演關鍵的角色
|
許文鴻;郭昭宏;郭富珍;吳宜真;陳君豪;許秉毅;陳和瑟;賴俊煌 |
| 國立臺灣大學 |
2006 |
Cyp2c9 Polymorphism and Warfarin Sensitivity in Taiwan Chinese
|
陳恆德; 翁祖輝; 鄭鈞文; CHERN, HERNG-DER; UENG, TZUU-HUEI; CHENG, CHUN-WEN |
| 國立臺灣大學 |
2006-12 |
CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese.
|
Chern, H.-D.; Ueng, T.-H.; Fu, Y.-P.; Cheng, C.-W. |
| 國立成功大學 |
1993 |
CYP2D 基因 C18 及 G4268 突變對藥品代謝的影響
|
黃金鼎 |
| 國立臺灣大學 |
2006 |
CYP2E1 AND XRCC1 GENETIC POLYMORPHISMS AND THE RISK OF LIVER FIBROSIS IN WORKERS EXPOSED TO VINYL CHLORIDE MONOMER
|
CHENG, TSUN-JEN; WANG, JUNG-DER; WONG, RUEY-HONG; HSIAO, TUN-JEN; 鄭尊仁; 王榮德; 翁瑞宏; 蕭敦仁 |
| 高雄醫學大學 |
2004 |
CYP2E1,GSTT1/M1基因多型性對職業苯暴露之尿中S-PMA生物偵測之影響
|
李曉雯;郭育良;廖寶琦;林隆晟;施政甫;莊弘毅;李姿瑜;黃奕孝;吳聰能;林雲卿;何啟功;石東生;張火炎 |
| 國立臺灣海洋大學 |
2005-02 |
CYP2K6 from zebrafish (Danio rerio): Cloning, mapping, developmental/tissue expression, and aflatoxin B1 activation by baculovirus expressed enzyme
|
J.L. Wang-Buhler;S.J. Lee;W.G. Chung;J.F. Stevens; H.P. Tseng;T.H. Hseu;C.H. Hu;M. Westerfield;Y.H. Yang;C.L. Miranda;D.R. Buhler |
| 國立成功大學 |
2010 |
CYP3A4基因調控及其受藥品與其他基因的影響
|
黃金鼎 |
| 國立成功大學 |
2011 |
CYP3A4基因調控及其受藥品與其他基因的影響
|
黃金鼎 |
| 國立成功大學 |
2009 |
CYP3A4基因調控及其受藥品與其他基因的影響
|
黃金鼎 |
| 中國醫藥大學 |
2003 |
CYP3A5*1 is an inhibitory factor for lung cancer in Taiwanese
|
葉坤土(Kun-Tu Yeh); 陳瑞彰(Jui-Chang Chen); 陳志玫(Chih-Mei Chen); 王郁芬(Yu-Feng Wang); 李黛苹(Tai-Ping Lee); 張建國(Jan-Gowth Chang)* |
| 中山醫學大學 |
2005 |
CYP3A5、PON2與GSTT1基因多形性對於農藥使用者其DNA傷害的效應
|
翁瑞宏; Weng, Jui-Hung |
| 中山醫學大學 |
2004-08-01 |
CYP3A5、PON2與GSTT1基因多形性對於農藥使用者其DNA傷害的效應
|
翁瑞宏 |
| 高雄醫學大學 |
2002 |
CYP3A5在骨髓性白血病之多形性分析
|
劉大智;林勝豐;陳田柏;張建國 ; Ta-Chih Liu;Sheng-Fung Lin;Tyen-Po Chen;Jan-Gowth Chang |
| 國立成功大學 |
2009-07-06 |
CYP3A5基因型對不同劑型之鈣離子阻斷劑nifedipine在藥物動力學上之影響
|
陳逸華; Chen, Yi-Hua |
| 國立成功大學 |
2010-07-22 |
CYP3A5基因型對不同劑型的鈣離子阻斷劑nifedipine在女性藥物動力學上的影響
|
林雅文; Lin, Ya-Wen |
| 國立臺灣海洋大學 |
2006-02-24 |
CYP3C1, the first member of a new cytochrome P450 subfamily found in zebrafish (Danio rerio)
|
Graham E. Corley-Smith;Hsiao-Ting Su;Jun-Lan Wang-Buhler;Hua-Pin Tseng;Chin-Hwa Hu;Thuy Hoang;Woon-Gye Chung;Donald R. Buhler |
| 中山醫學大學 |
2018-07-02 |
CYP450-mediated mitochondrial ROS production involved in arecoline N-oxide-induced oxidative damage in liver cell lines
|
Tsu-Shing Wang; Cheng-Ping Lin; Yu-Pong Chen; Mu-Rong Chao; Chien-Chun Li; Kai-Li Liu |
| 國立東華大學 |
2009-12 |
Cyperus Surinamensis Rottb., a Newly Naturalized Sedge Species in Taiwan
|
陳世輝;翁書慧;吳明洲; Chen, Shih-Huei;Weng, Shu-Huei;Wu, Ming-Jou |
